TY - JOUR
TI - Joint ESH excellence centers' national meeting on renal sympathetic
denervation: A Greek experts' survey
AU - Doumas, Michael
AU - Andreadis, Emmanouil
AU - Andronoglou, Markos and
AU - Davlouros, Periklis
AU - Dimitriadis, Kyriakos
AU - Gkaliagkousi, Eugene
AU - and Grassos, Harris
AU - Hatzitolios, Apostolos
AU - Iliakis, Panagiotis
AU - and Kalaitzidis, Rigas
AU - Kallistratos, Emmanouil
AU - Kasiakogias,
AU - Alexandros
AU - Konstantinidis, Dimitrios
AU - Kotsis, Vasilios and
AU - Makris, Thomas
AU - Manolis, Athanasios
AU - Moulias, Athanasios and
AU - Marketou, Maria
AU - Papadakis, Ioannis
AU - Papadopoulos, Dimitrios and
AU - Poulimenos, Leonidas
AU - Sanidas, Elias
AU - Sarafidis, Pantelis and
AU - Savopoulos, Christos
AU - Stergiou, George
AU - Tatakis, Fotis and
AU - Thomopoulos, Konstantinos
AU - Triantafyllidi, Helen
AU - Triantafyllou,
AU - Areti
AU - Vlachakos, Dimitrios
AU - Zebekakis, Pantelis
AU - Ziakas,
AU - Antonios
AU - Papademetriou, Vasilios
AU - Tsioufi, Costas
AU - Task Force
AU - Greek ESH Excelle
JO - Ελληνική καρδιολογική επιθεώρηση
PY - 2021
VL - 62
TODO - 5
SP - 355-358
PB - HELLENIC CARDIOLOGICAL SOC
SN - 1011-7970
TODO - 10.1016/j.hjc.2021.04.003
TODO - renal denervation; hypertension; safety; efficacy; Greek hypertension
experts
TODO - Objective: The efficacy of renal sympathetic denervation (RDN) has been
affirmed by a number of recent clinical studies, despite controversies
in this field over the last five years. Therefore, it is of paramount
importance that hypertension experts debate the merits of RDN by
revealing and expressing their personal beliefs and perspectives
regarding this procedure. Methods: A cross-sectional survey was
conducted among Greek leaders of the Hypertension Excellence Centers
with the use of a closed-type questionnaire specifically designed to
elicit information and evaluate the respondent’s views and perspectives
about RDN efficacy, safety and ideal target patient population. Results:
A total of 36 participants completed the survey. Based on the results,
RDN was considered efficient (91.7%) and safe (94.5%), while the
overwhelming majority of the participants felt confident in the
long-term efficacy (88.9%) of the intervention and that it lacks
reliable predictors of blood pressure response (94.5%). Patients with
resistant (91.7%), ultra-resistant (94.4%), and uncontrolled
hypertension (80.6%) were suggested as ideal candidates for RDN.
Establishing a close co-operation between interventionalists and
hypertension experts was considered essential to ensure the efficacy
(97.2%) as well as the safety (97.3%) of the procedure. Conclusion:
The vast majority of Greek hypertension experts surveyed were convinced
of the efficacy and safety of RDN based on the preponderance of
available scientific and clinical data. Identification of the ideal
patient group remains controversial. Respondents generally agreed on the
necessity of building close collaborative relationships between
interventionalists and hypertension experts in order to improve RDN
clinical outcome. (c) 2021 Hellenic Society of Cardiology. Publishing
services by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ER -